FDA OKs Vitamin C Trial For Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Federal approval of a clinical trial on intravenous vitamin C as a cancer treatment lends credence to alternative cancer care, U.S. researchers said. Cancer Treatment Centers of America said it won Food and Drug Administration approval to begin the trial, a move the Illinois- based hospital group said adds credibility to its research into alternative methods for cancer medical care, the Chicago Tribune said Thursday. It is the first FDA-approved trial for CTCA.

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.